BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li MY, Deng H, Zhao JM, Dai D, Tan XY. Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells. World J Gastroenterol 2003; 9(8): 1683-1688 [PMID: 12918101 DOI: 10.3748/wjg.v9.i8.1683]
URL: https://www.wjgnet.com/1007-9327/full/v9/i8/1683.htm
Number Citing Articles
1
Aurora Aiello, Giuseppe Pandini, Francesco Frasca, Enrico Conte, Antonella Murabito, Antonella Sacco, Marco Genua, Riccardo Vigneri, Antonino Belfiore. Peroxisomal Proliferator-Activated Receptor-γ Agonists Induce Partial Reversion of Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer CellsEndocrinology 2006; 147(9): 4463 doi: 10.1210/en.2005-1610
2
Yvonne Y. Shao, Lai Wang, David G. Hicks, Shannon Tarr, R. Tracy Ballock. Expression and activation of peroxisome proliferator-activated receptors in growth plate chondrocytesJournal of Orthopaedic Research 2005; 23(5): 1139 doi: 10.1016/j.orthres.2005.02.011
3
A. Belfiore, M. Genua, R. Malaguarnera. PPAR-γAgonists and Their Effects on IGF-I Receptor Signaling: Implications for CancerPPAR Research 2009; 2009: 1 doi: 10.1155/2009/830501
4
Yifeng He, Haijian Li, Yunhe He, Caijie Lu, Peiyi Zhu, Mingyi Li, Juan Duan, Zhixin Fang. Troglitazone inhibits hepatic oval cell proliferation by inducing cell cycle arrest through Hippo/YAP pathway regulationDigestive and Liver Disease 2022; 54(6): 791 doi: 10.1016/j.dld.2021.08.018
5
Hyo Jung Kim, Im Sun Woo, Eun Sil Kang, So Young Eun, Gil Hyeong Kim, Sun Ah Ham, Hye Jung Kim, Jae Heun Lee, Ki Churl Chang, Jin-Hoi Kim, Hoon Taek Lee, Han Geuk Seo. Phorbol ester potentiates the growth inhibitory effects of troglitazone via up-regulation of PPARγ in A549 cellsBiochemical and Biophysical Research Communications 2006; 349(2): 660 doi: 10.1016/j.bbrc.2006.08.085
6
Bo Zheng, Yan-Jing Zhu, Hong-Yang Wang, Lei Chen. Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanismsScience China Life Sciences 2017; 60(6): 575 doi: 10.1007/s11427-016-9043-9
7
He-Sheng Luo, Hong-Gang Yu, Yan-Hong Zhou, Xiang-Zhi Meng, Jie-Ping Yu, Mei Ming. Effect of ligand troglitazone on peroxisome proliferator-activated receptor γ expression and cellular growth in human colon cancer cellsWorld Journal of Gastroenterology 2006; 12(45): 7263-7270 doi: 10.3748/wjg.v12.i45.7263
8
Liwei Wu, Chuanyong Guo, Jianye Wu. Therapeutic potential of PPARγ natural agonists in liver diseasesJournal of Cellular and Molecular Medicine 2020; 24(5): 2736 doi: 10.1111/jcmm.15028
9
E. Bugianesi. Non-alcoholic Steatohepatitis and CancerClinics in Liver Disease 2007; 11(1): 191 doi: 10.1016/j.cld.2007.02.006
10
Melody Chiu, Lucien McBeth, Puneet Sindhwani, Terry D. Hinds. Deciphering the Roles of Thiazolidinediones and PPARγin Bladder CancerPPAR Research 2017; 2017: 1 doi: 10.1155/2017/4810672
11
C. Bonne. Le PPAR gamma : une nouvelle cible pharmacologique contre la néovascularisation rétinienne et choroïdienneJournal Français d'Ophtalmologie 2005; 28(3): 326 doi: 10.1016/S0181-5512(05)81062-9
12
Lorne J. Hofseth, Lei Ying. Identifying and defusing weapons of mass inflammation in carcinogenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2006; 1765(1): 74 doi: 10.1016/j.bbcan.2005.08.005
13
Sharon E Campbell, William L Stone, Steven Lee, Sarah Whaley, Hongsong Yang, Min Qui, Paige Goforth, Devin Sherman, Derek McHaffie, Koyamangalath Krishnan. Comparative effects of RRR-alpha- and RRR-gamma-tocopherol on proliferation and apoptosis in human colon cancer cell linesBMC Cancer 2006; 6(1) doi: 10.1186/1471-2407-6-13
14
Alexandra Rogue, Catherine Spire, Manuel Brun, Nancy Claude, André Guillouzo. Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human LiverPPAR Research 2010; 2010: 1 doi: 10.1155/2010/325183
15
Marwa M. Ahmad, Noha A. Rezk, Amal Fawzy, Mohamed Sabry. Protective effects of curcumin and silymarin against paracetamol induced hepatotoxicity in adult male albino ratsGene 2019; 712: 143966 doi: 10.1016/j.gene.2019.143966
16
Atef A. El-Hela, Marwa S. Abu Bakr, Mostafa M. Hegazy, Mohammed A. Dahab, Ayman Abo Elmaaty, Adel Ehab Ibrahim, Sami El Deeb, Hatem S. Abbass. Phytochemical Characterization of Pterocephalus frutescens with In-Silico Evaluation as Chemotherapeutic Medicine and Oral Pharmacokinetics Prediction StudyScientia Pharmaceutica 2023; 91(1): 7 doi: 10.3390/scipharm91010007
17
J. C. Gaston Wu, Ya-Ping Su, Jian-Ling Wang, Lei Yan, You-Yong Lu, Kung-Tung Chen, Yi-Qun Gu, Guang Jia. Protective role of metallothionein (I/II) against pathological damage and apoptosis induced by dimethylarsinic acidWorld Journal of Gastroenterology 2004; 10(1): 91-95 doi: 10.3748/wjg.v10.i1.91
18
Ivan Borbath, Yves Horsmans. The Role of PPAR in Hepatocellular CarcinomaPPAR Research 2008; 2008: 1 doi: 10.1155/2008/209520
19
Xudong Wu, Weichang Chen, Suqing Zhang. Peroxisome proliferator-activated receptor γ expression correlates with tumor angiogenesis in human hepatocellular carcinomaThe Chinese-German Journal of Clinical Oncology 2008; 7(5): 266 doi: 10.1007/s10330-008-0022-2
20
Vikram Patial, Vinesh Sharma, Swati Katoch. Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenariosWorld Journal of Gastroenterology 2022; 28(28): 3535-3554 doi: 10.3748/wjg.v28.i28.3535
21
Sapana Bansod, Mohd Aslam Saifi, Chandraiah Godugu. Molecular updates on berberine in liver diseases: Bench to bedsidePhytotherapy Research 2021; 35(10): 5459 doi: 10.1002/ptr.7181
22
Belinda Knight, Bu B. Yeap, George C. Yeoh, John K. Olynyk. Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member γ, but not α or δCarcinogenesis 2005; 26(10): 1782 doi: 10.1093/carcin/bgi138
23
Jai Prakash, Ruchi Bansal, Eduard Post, Alie de Jager-Krikken, Marjolijn N. Lub-de Hooge, Klaas Poelstra. Albumin-Binding and Tumor Vasculature Determine the Antitumor Effect of 15-Deoxy-Δ12,14-Prostaglandin-J2in vivoNeoplasia 2009; 11(12): 1348 doi: 10.1593/neo.91188
24
YUEH-MIN LIN, BHARATH KUMAR VELMURUGAN, YU-LAN YEH, CHUAN CHOU TU, TSUNG-JUNG HO, TUNG YUAN LAI, CHIH-HAO TSAI, FUU JEN TSAI, CHANG-HAI TSAI, CHIH-YANG HUANG. Activation of estrogen receptors with E2 downregulates peroxisome proliferator-activated receptor γ in hepatocellular carcinomaOncology Reports 2013; 30(6): 3027 doi: 10.3892/or.2013.2793
25
Cai-Yan Zhao, Ling-Ling Jiang, Li Li, Zhuo-Jun Deng, Bao-Li Liang, Jian-Mei Li. Peroxisome proliferator activated receptor-γ in pathogenesis of experimental fatty liver diseaseWorld Journal of Gastroenterology 2004; 10(9): 1329-1332 doi: 10.3748/wjg.v10.i9.1329